AAAAAA
Results: 1-25/33
Authors:
Drucker, DJ
Citation: Dj. Drucker, Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes, CUR PHARM D, 7(14), 2001, pp. 1399-1412
Authors:
Ling, Z
Wu, D
Zambre, Y
Flamez, D
Drucker, DJ
Pipeleers, DG
Schuit, FC
Citation: Z. Ling et al., Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice, VIRCHOWS AR, 438(4), 2001, pp. 382-387
Authors:
Lefebvre, DL
Bai, YH
Shahmolky, N
Sharma, M
Poon, R
Drucker, DJ
Rosen, CF
Citation: Dl. Lefebvre et al., Identification and characterization of a novel sucrose-non-fermenting protein kinase/AMP-activated protein kinase-related protein kinase, SNARK, BIOCHEM J, 355, 2001, pp. 297-305
Authors:
Drucker, DJ
Citation: Dj. Drucker, Glucagon-like peptide 2, J CLIN END, 86(4), 2001, pp. 1759-1764
Authors:
Lovshin, J
Estall, J
Yusta, B
Brown, TJ
Drucker, DJ
Citation: J. Lovshin et al., Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling, J BIOL CHEM, 276(24), 2001, pp. 21489-21499
Authors:
Drucker, DJ
Citation: Dj. Drucker, Minireview: The glucagon-like peptides, ENDOCRINOL, 142(2), 2001, pp. 521-527
Authors:
Boushey, RP
Yusta, B
Drucker, DJ
Citation: Rp. Boushey et al., Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor, CANCER RES, 61(2), 2001, pp. 687-693
Authors:
Xiao, Q
Boushey, RP
Cino, M
Drucker, DJ
Brubaker, PL
Citation: Q. Xiao et al., Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease, AM J P-REG, 278(4), 2000, pp. R1057-R1063
Authors:
Tavares, W
Drucker, DJ
Brubaker, PL
Citation: W. Tavares et al., Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats, AM J P-ENDO, 278(1), 2000, pp. E134-E139
Authors:
Lovshin, J
Drucker, DJ
Citation: J. Lovshin et Dj. Drucker, New frontiers in the biology of GLP-2, REGUL PEPT, 90(1-3), 2000, pp. 27-32
Authors:
Marguet, D
Baggio, L
Kobayashi, T
Bernard, AM
Pierres, M
Nielsen, PF
Ribel, U
Watanabe, T
Drucker, DJ
Wagtmann, N
Citation: D. Marguet et al., Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26, P NAS US, 97(12), 2000, pp. 6874-6879
Authors:
Elias, CF
Kelly, JF
Lee, CE
Ahima, RS
Drucker, DJ
Saper, CB
Elmquist, JK
Citation: Cf. Elias et al., Chemical characterization of leptin-activated neurons in the rat brain, J COMP NEUR, 423(2), 2000, pp. 261-281
Authors:
Yusta, B
Boushey, RP
Drucker, DJ
Citation: B. Yusta et al., The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway, J BIOL CHEM, 275(45), 2000, pp. 35345-35352
Authors:
Baggio, L
Adatia, F
Bock, T
Brubaker, PL
Drucker, DJ
Citation: L. Baggio et al., Sustained expression of exendin-4 does not perturb glucose homeostasis, beta-cell mass, or food intake in metallothionein-preproexendin transgenic mice, J BIOL CHEM, 275(44), 2000, pp. 34471-34477
Authors:
Yusta, B
Huang, L
Munroe, D
Wolff, G
Fantaske, R
Sharma, S
Demchyshyn, L
Asa, SL
Drucker, DJ
Citation: B. Yusta et al., Enteroendocrine localization of GLP-2 receptor expression in humans and rodents, GASTROENTY, 119(3), 2000, pp. 744-755
Authors:
MacLusky, NJ
Cook, S
Scrocchi, L
Shin, J
Kim, J
Vaccarino, F
Asa, SL
Drucker, DJ
Citation: Nj. Maclusky et al., Neuroendocrine function and response to stress mice with complete disruption of glucagon-like peptide-1 receptor signaling, ENDOCRINOL, 141(2), 2000, pp. 752-762
Authors:
Lovshin, J
Yusta, B
Iliopoulos, I
Migirdicyan, A
Dableh, L
Brubaker, PL
Drucker, DJ
Citation: J. Lovshin et al., Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine, ENDOCRINOL, 141(11), 2000, pp. 4194-4201
Authors:
Baggio, L
Kieffer, TJ
Drucker, DJ
Citation: L. Baggio et al., Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide,regulates fasting glycemia and nonenteral glucose clearance in mice, ENDOCRINOL, 141(10), 2000, pp. 3703-3709
Authors:
Scrocchi, LA
Hill, ME
Saleh, J
Perkins, B
Drucker, DJ
Citation: La. Scrocchi et al., Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action, DIABETES, 49(9), 2000, pp. 1552-1560
Authors:
Stoffers, DA
Kieffer, TJ
Hussain, MA
Drucker, DJ
Bonner-Weir, S
Habener, JF
Egan, JM
Citation: Da. Stoffers et al., Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas, DIABETES, 49(5), 2000, pp. 741-748
Authors:
DaCambra, MP
Yusta, B
Sumner-Smith, M
Crivici, A
Drucker, DJ
Brubaker, PL
Citation: Mp. Dacambra et al., Structural determinants for activity of glucagon-like peptide-2, BIOCHEM, 39(30), 2000, pp. 8888-8894
Authors:
Drucker, DJ
Citation: Dj. Drucker, Glucagon-like peptide 2, TRENDS ENDO, 10(4), 1999, pp. 153-156
Authors:
Kaestner, KH
Katz, J
Liu, YF
Drucker, DJ
Schutz, G
Citation: Kh. Kaestner et al., Inactivation of the winged helix transcription factor HNF3 alpha affects glucose homeostasis and islet glucagon gene expression in vivo, GENE DEV, 13(4), 1999, pp. 495-504
Authors:
Hill, ME
Asa, SL
Drucker, DJ
Citation: Me. Hill et al., Essential requirement for Pax6 in control of enteroendocrine proglucagon gene transcription, MOL ENDOCR, 13(9), 1999, pp. 1474-1486
Human [Gly(2)]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis
Authors:
Drucker, DJ
Yusta, B
Boushey, RP
DeForest, L
Brubaker, PL
Citation: Dj. Drucker et al., Human [Gly(2)]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis, AM J P-GAST, 39(1), 1999, pp. G79-G91